Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3467 | 1496 | 33.7 | 53% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
658 | 3 | COENZYME Q10//UBIQUINONE//COENZYME Q | 11100 |
3467 | 2 | CITICOLINE//CDP CHOLINE//ACETYL L CARNITINE | 1496 |
18058 | 1 | ACETYL L CARNITINE//PHARMACOL PHARMACOL BIOTECHNOL//PHARMACOL MOL MED CENT NERVOUS SYST | 569 |
20549 | 1 | CITICOLINE//CDP CHOLINE//CHOLINE ALPHOSCERATE | 455 |
22910 | 1 | ALMITRINE//ALMITRINE BISMESYLATE//ALMITRINE RAUBASINE | 364 |
34649 | 1 | 3 4 DIHYDROXYPHENYLPYRIVIC ACID//CORTISOL STIMULATION TEST//DIABETIC ANGIOPATHIES PHYSIOPATHOLOGY | 108 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CITICOLINE | authKW | 1712399 | 7% | 82% | 102 |
2 | CDP CHOLINE | authKW | 850231 | 5% | 59% | 71 |
3 | ACETYL L CARNITINE | authKW | 593507 | 6% | 32% | 92 |
4 | ALMITRINE | authKW | 293528 | 2% | 55% | 26 |
5 | CHOLINE ALPHOSCERATE | authKW | 222232 | 1% | 78% | 14 |
6 | PHARMACOL MOL MED CENT NERVOUS SYST | address | 170077 | 1% | 83% | 10 |
7 | PHARMACOL PHARMACOL BIOTECHNOL | address | 170077 | 1% | 83% | 10 |
8 | NEUROCHEM MOL MED | address | 130619 | 1% | 80% | 8 |
9 | ALMITRINE BISMESYLATE | authKW | 127162 | 1% | 69% | 9 |
10 | CYTIDINE 5 DIPHOSPHOCHOLINE | authKW | 110205 | 1% | 60% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 3175 | 28% | 0% | 421 |
2 | Pharmacology & Pharmacy | 2588 | 26% | 0% | 386 |
3 | Respiratory System | 2247 | 11% | 0% | 158 |
4 | BIOLOGY, MISCELLANEOUS | 2216 | 1% | 1% | 13 |
5 | MEDICINE, MISCELLANEOUS | 2162 | 1% | 1% | 13 |
6 | Geriatrics & Gerontology | 1175 | 5% | 0% | 75 |
7 | Clinical Neurology | 1013 | 13% | 0% | 189 |
8 | Psychiatry | 222 | 5% | 0% | 82 |
9 | Biochemistry & Molecular Biology | 203 | 14% | 0% | 212 |
10 | Medicine, General & Internal | 151 | 6% | 0% | 95 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL MOL MED CENT NERVOUS SYST | 170077 | 1% | 83% | 10 |
2 | PHARMACOL PHARMACOL BIOTECHNOL | 170077 | 1% | 83% | 10 |
3 | NEUROCHEM MOL MED | 130619 | 1% | 80% | 8 |
4 | PHYSIOL PHARMACOL CELLULAR MOL SCI | 97238 | 1% | 53% | 9 |
5 | FORENS MED PHARMACOL TOXICOL SCI | 45920 | 0% | 75% | 3 |
6 | ANAT HYSTOL FORENS MED | 40819 | 0% | 100% | 2 |
7 | HALLYM EPILEPSY | 40819 | 0% | 100% | 2 |
8 | NEUROPATOL ICS | 40819 | 0% | 100% | 2 |
9 | RIC CLIN SCI FARM PROD SALUTE | 40819 | 0% | 100% | 2 |
10 | PHARMACOL TOXICOL SCI | 36735 | 0% | 60% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY | 33922 | 2% | 5% | 32 |
2 | REVUE FRANCAISE DES MALADIES RESPIRATOIRES | 31643 | 1% | 10% | 15 |
3 | EUROPEAN JOURNAL OF RESPIRATORY DISEASES | 16514 | 2% | 2% | 34 |
4 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 14366 | 2% | 3% | 26 |
5 | NEUROCHEMICAL RESEARCH | 10711 | 4% | 1% | 62 |
6 | KOSMICHESKAYA BIOLOGIYA I AVIAKOSMICHESKAYA MEDITSINA | 4397 | 1% | 2% | 13 |
7 | ANNALES DE L ANESTHESIOLOGIE FRANCAISE | 3743 | 0% | 6% | 3 |
8 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3597 | 2% | 1% | 28 |
9 | BIOMEDICA BIOCHIMICA ACTA | 3550 | 1% | 1% | 19 |
10 | ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 3144 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CITICOLINE | 1712399 | 7% | 82% | 102 | Search CITICOLINE | Search CITICOLINE |
2 | CDP CHOLINE | 850231 | 5% | 59% | 71 | Search CDP+CHOLINE | Search CDP+CHOLINE |
3 | ACETYL L CARNITINE | 593507 | 6% | 32% | 92 | Search ACETYL+L+CARNITINE | Search ACETYL+L+CARNITINE |
4 | ALMITRINE | 293528 | 2% | 55% | 26 | Search ALMITRINE | Search ALMITRINE |
5 | CHOLINE ALPHOSCERATE | 222232 | 1% | 78% | 14 | Search CHOLINE+ALPHOSCERATE | Search CHOLINE+ALPHOSCERATE |
6 | ALMITRINE BISMESYLATE | 127162 | 1% | 69% | 9 | Search ALMITRINE+BISMESYLATE | Search ALMITRINE+BISMESYLATE |
7 | CYTIDINE 5 DIPHOSPHOCHOLINE | 110205 | 1% | 60% | 9 | Search CYTIDINE+5+DIPHOSPHOCHOLINE | Search CYTIDINE+5+DIPHOSPHOCHOLINE |
8 | CYTIDINE | 88958 | 1% | 20% | 22 | Search CYTIDINE | Search CYTIDINE |
9 | CHOLINERGIC PRECURSORS | 85039 | 0% | 83% | 5 | Search CHOLINERGIC+PRECURSORS | Search CHOLINERGIC+PRECURSORS |
10 | ALMITRINE RAUBASINE | 81635 | 0% | 67% | 6 | Search ALMITRINE+RAUBASINE | Search ALMITRINE+RAUBASINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SECADES, JJ , (2011) CITICOLINE: PHARMACOLOGICAL AND CLINICAL REVIEW, 2010 UPDATE.REVISTA DE NEUROLOGIA. VOL. 52. ISSUE . P. S1 -S62 | 185 | 67% | 27 |
2 | SECADES, JJ , LORENZO, JL , (2006) CITICOLINE: PHARMACOLOGICAL AND CLINICAL REVIEW, 2006 UPDATE.METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY. VOL. 28. ISSUE . P. 1 -56 | 145 | 69% | 65 |
3 | GRIEB, P , (2014) NEUROPROTECTIVE PROPERTIES OF CITICOLINE: FACTS, DOUBTS AND UNRESOLVED ISSUES.CNS DRUGS. VOL. 28. ISSUE 3. P. 185-193 | 44 | 73% | 13 |
4 | SECADES, JJ , FRONTERA, G , (1995) CDP-CHOLINE - PHARMACOLOGICAL AND CLINICAL REVIEW.METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY. VOL. 17. ISSUE . P. 1-54 | 61 | 75% | 59 |
5 | VILLA, RF , FERRARI, F , GORINI, A , (2013) ATP-ASES OF SYNAPTIC PLASMA MEMBRANES IN STRIATUM: ENZYMATIC SYSTEMS FOR SYNAPSES FUNCTIONALITY BY IN VIVO ADMINISTRATION OF L-ACETYLCARNITINE IN RELATION TO PARKINSON'S DISEASE.NEUROSCIENCE. VOL. 248. ISSUE . P. 414 -426 | 51 | 54% | 1 |
6 | VILLA, RF , FERRARI, F , GORINI, A , (2011) EFFECT OF IN VIVO L-ACETYLCARNITINE ADMINISTRATION ON ATP-ASES ENZYME SYSTEMS OF SYNAPTIC PLASMA MEMBRANES FROM RAT CEREBRAL CORTEX.NEUROCHEMICAL RESEARCH. VOL. 36. ISSUE 8. P. 1372 -1382 | 40 | 69% | 3 |
7 | CANER, B , KAFA, MI , BEKAR, A , KURT, MA , KARLI, N , CANSEV, M , ULUS, IH , (2012) INTRAPERITONEAL ADMINISTRATION OF CDP-CHOLINE OR A COMBINATION OF CYTIDINE PLUS CHOLINE IMPROVES NERVE REGENERATION AND FUNCTIONAL RECOVERY IN A RAT MODEL OF SCIATIC NERVE INJURY.NEUROLOGICAL RESEARCH. VOL. 34. ISSUE 3. P. 238-245 | 31 | 79% | 2 |
8 | SCHABITZ, WR , (2009) CDP-CHOLINE FOR THE TREATMENT OF STROKE.PSYCHOPHARMAKOTHERAPIE. VOL. 16. ISSUE 3. P. 101-+ | 28 | 93% | 1 |
9 | JONES, LL , MCDONALD, DA , BORUM, PR , (2010) ACYLCARNITINES: ROLE IN BRAIN.PROGRESS IN LIPID RESEARCH. VOL. 49. ISSUE 1. P. 61-75 | 57 | 34% | 99 |
10 | WEISS, GB , (1995) METABOLISM AND ACTIONS OF CDP-CHOLINE AS AN ENDOGENOUS COMPOUND AND ADMINISTERED EXOGENOUSLY AS CITICOLINE.LIFE SCIENCES. VOL. 56. ISSUE 9. P. 637 -660 | 61 | 54% | 118 |
Classes with closest relation at Level 2 |